Literature DB >> 34408003

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.

Massimiliano Di Filippo1, Cinzia Cordioli2, Simona Malucchi3, Pietro Annovazzi4, Paola Cavalla5, Valentina Torri Clerici6, Paolo Ragonese7, Viviana Nociti8, Marta Radaelli9, Alice Laroni10, Fabio Buttari11, Lorena Lorefice12, Diana Ferraro13, Alberto Gajofatto14, Luca Prosperini15, Roberta Fantozzi11, Laura Boffa16, Roberta Lanzillo17, Marcello Moccia17, Marinella Clerico18, Giovanna De Luca19, Valentina Tomassini19,20, Massimiliano Calabrese21, Angela Borrelli22, Damiano Paolicelli23, Giorgia Teresa Maniscalco24, Paola Gazzola25, Antonio Gallo26, Claudio Solaro27, Eleonora Cocco28, Claudio Gasperini15, Carla Tortorella15.   

Abstract

Entities:  

Keywords:  COVID-19; multiple sclerosis; neuroimmunology

Mesh：

Substances：

Year:  2021        PMID： 34408003     DOI： 10.1136/jnnp-2021-327200

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  19 in total

1.  Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.

Authors:  Carlos Quintanilla-Bordás; Francisco Gascón-Gimenez; Carmen Alcalá; María Payá; Javier Mallada; Raquel Silla; Sara Carratalà-Boscà; Raquel Gasque-Rubio; Jessica Castillo; Bonaventura Casanova
Journal:  Front Neurol       Date:  2022-04-27       Impact factor: 4.086

2.  Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD.

Authors:  Alessandro Dinoto; Elia Sechi; Sergio Ferrari; Alberto Gajofatto; Riccardo Orlandi; Paolo Solla; Alessandra Maccabeo; Giorgia Teresa Maniscalco; Vincenzo Andreone; Arianna Sartori; Paolo Manganotti; Sarah Rasia; Ruggero Capra; Chiara Rosa Mancinelli; Sara Mariotto
Journal:  Mult Scler Relat Disord       Date:  2021-11-22       Impact factor: 4.339

3.  COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper.

Authors:  Martin Rakusa; Serefnur Öztürk; Elena Moro; Raimund Helbok; Claudio L Bassetti; Ettore Beghi; Daniel Bereczki; Benedetta Bodini; Giovanni Di Liberto; Thomas M Jenkins; Antonella Macerollo; Luis F Maia; Filippo Martinelli-Boneschi; Antonio Pisani; Alberto Priori; Anna Sauerbier; Riccardo Soffietti; Pille Taba; Tim J von Oertzen; Marialuisa Zedde; Michael Crean; Anja Burlica; Francesco Cavallieri; Johann Sellner
Journal:  Eur J Neurol       Date:  2022-05-10       Impact factor: 6.288

4.  Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.

Authors:  Tiziana Lazzarotto; Rocco Liguori; Maria Pia Giannoccaro; Veria Vacchiano; Marta Leone; Federico Camilli; Corrado Zenesini; Ivan Panzera; Alice Balboni; Maria Tappatà; Annamaria Borghi; Fabrizio Salvi; Alessandra Lugaresi; Rita Rinaldi; Giulia Di Felice; Vittorio Lodi
Journal:  J Neurol       Date:  2022-05-03       Impact factor: 6.682

Review 5.  Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach.

Authors:  Paolo Immovilli; Nicola Morelli; Chiara Terracciano; Eugenia Rota; Elena Marchesi; Stefano Vollaro; Paola De Mitri; Domenica Zaino; Veronica Bazzurri; Donata Guidetti
Journal:  Neurol Int       Date:  2022-04-15

6.  Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders.

Authors:  Alessandro Dinoto; Matteo Gastaldi; Raffaele Iorio; Sofia Marini; Valentina Damato; Antonio Farina; Marco Zoccarato; Elia Sechi; Francesca Pinna; Giorgia Teresa Maniscalco; Ruggero Barnabei; Luigi Zuliani; Sergio Ferrari; Sara Mariotto
Journal:  Mult Scler Relat Disord       Date:  2022-04-25       Impact factor: 4.808

7.  MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report.

Authors:  Jordi Kühne Escolà; Cornelius Deuschl; Andreas Junker; Fabian Dusse; Refik Pul; Christoph Kleinschnitz; Martin Köhrmann; Benedikt Frank
Journal:  Ther Adv Neurol Disord       Date:  2022-01-19       Impact factor: 6.570

8.  COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases.

Authors:  Larisa Pinte; Florentina Negoi; Georgeta Daniela Ionescu; Simona Caraiola; Daniel Vasile Balaban; Camelia Badea; Diana Mazilu; Bianca Dumitrescu; Bogdan Mateescu; Ruxandra Ionescu; Magda Ileana Parvu; Cristian Baicus
Journal:  J Pers Med       Date:  2021-12-02

9.  Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection.

Authors:  Antonia Pignolo; Maria Aprile; Cesare Gagliardo; Giovanni Maurizio Giammanco; Marco D'Amelio; Paolo Aridon; Giuseppe La Tona; Giuseppe Salemi; Paolo Ragonese
Journal:  Neurol Int       Date:  2021-12-06

10.  Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine.

Authors:  Ian Fyfe
Journal:  Nat Rev Neurol       Date:  2021-10       Impact factor: 42.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.